APC2 Inhibitors

APC2 inhibitors, also known as Anaphase-Promoting Complex 2 inhibitors, belong to a class of compounds that play a pivotal role in regulating cell cycle progression and maintaining genomic stability. These inhibitors target a key component of the ubiquitin-proteasome system, the Anaphase-Promoting Complex 2 (APC2), which is responsible for orchestrating the degradation of specific proteins at precise points in the cell cycle. The APC2 is a multi-subunit E3 ubiquitin ligase that primarily functions during mitosis and G1 phase to control the orderly progression of the cell cycle. It acts by tagging target proteins with ubiquitin molecules, marking them for degradation by the proteasome, thereby ensuring that cells progress through the cell cycle in a highly regulated manner.

APC2 inhibitors are designed to interfere with the activity of the APC2 complex, preventing it from recognizing and ubiquitinating its target proteins. These compounds typically bind to specific sites on the APC2 protein, disrupting its function and leading to the accumulation of critical cell cycle regulators. The inhibition of APC2 activity can have profound effects on cell cycle regulation, ultimately impacting cell proliferation, differentiation, and cell fate determination. Researchers and scientists studying the cell cycle and related cellular processes often employ APC2 inhibitors as valuable tools in their investigations.